TLR8, N-(4-(3,5-bis(trifluoromethyl)phenoxy)phenyl)-2-fluoro-6-iodobenzamide, CU115, CU-115, CU 115
CU-115 is a potent and selective TLR8 antagonist (IC50 = 1.04 µM) that shows minimal activity against TLR7 (>50 µM). It effectively inhibits R-848-induced TNF-alpha and IL-1beta production in THP-1 cells, making it a valuable tool for studying TLR8-mediated signaling in autoimmune and inflammatory disease research.